Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Inman KR et al. – In obese patients or those with heparin resistance, subcutaneous lepirudin can be monitored and the regimen adjusted based on aPTT values. Further studies are warranted to maximize efficacy and define dosing.

Related Articles

Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain
AIDS Research and Human Retroviruses, 10/23/09    Relevance Score: 46%

Incidence and causes of heparin-induced skin lesions
Canadian Medical Association Journal, 10/19/09    Relevance Score: 46%

Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Clinical Microbiology Reviews, 10/14/09    Relevance Score: 46%

Age-Associated Increase in Abdominal Obesity and Insulin Resistance, and Usefulness of AHA/NHLBI Definition of Metabolic Syndrome for Predicting Cardiovascular Disease in Japanese Elderly with Type 2 Diabetes Mellitus
Gerontology, 10/19/09    Relevance Score: 45%

New USP Standard for Heparin Decreases Unit Dose Potency, Dictates Careful Monitoring
American Family Physician, 10/09/09    Relevance Score: 45%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address